Tag: biopharmaceutical

namilumab

Phase II proof-of-concept clinical study of Namilumab for ankylosing spondylitis initiated

Izana Bioscience, a biopharmaceutical company focused on translational medicine, has announced the initiation of a phase II proof-of-concept clinical study of namilumab in ankylosing...